Clinical Web Archive

Sign in Subscribe

Oncology

Effectiveness, safety, and the abscopal effect of stereotactic body radiation therapy combined with immune checkpoint inhibitors in advanced gastrointestinal cancers: a systematic review and meta-analysis

Effectiveness, safety, and the abscopal effect of stereotactic body radiation therapy combined with immune checkpoint inhibitors in advanced gastrointestinal cancers: a systematic review and meta-analysis

Quick Take: Combining SBRT with immune checkpoint inhibitors (ICIs) shows early signal for advanced gastrointestinal cancers, though it remains strictly investigational. 💡 Clinical Impact * Novel Synergy: SBRT may act as an "in situ vaccine," potentially overcoming the immunosuppressive microenvironment typical of GI malignancies. * Systemic Potential: Early data suggests the

Effectiveness of oral mucositis management based on MASCC/ISOO guidelines in pediatric oncology patients: a randomized controlled trial

Quick Take: Adherence to MASCC/ISOO guidelines effectively improves outcomes for pediatric oncology patients with oral mucositis. 💡 Clinical Impact * Patient Morbidity: Reduces the severe pain, feeding difficulties, and infection risk associated with oral mucositis, significantly improving quality of life for a highly vulnerable patient population. * Treatment Efficacy: Minimizes treatment delays

Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials.

Quick Take: VATS lobectomy for lung cancer delivers survival outcomes equivalent to open lobectomy, solidifying its role as a preferred surgical approach when technically feasible. 💡 Clinical Impact * Reinforces current practice by validating that minimally invasive VATS does not compromise long-term oncologic survival compared to open surgery. * Supports continued patient selection

JK5G postbiotics modulate gut microbiota and metabolome to alleviate cancer-related pain: a randomized controlled trial with multi-omics integration

Quick Take: JK5G postbiotics demonstrate early potential to modulate gut microbiota and metabolome, offering a novel, non-pharmacological approach for cancer-related pain in chemotherapy patients. 💡 Clinical Impact * Presents a potential non-opioid strategy for cancer-related pain, addressing an unmet need for alternative analgesia with fewer side effects. * Highlights the gut-brain axis as